Literature DB >> 15830826

An introduction to economic evaluation: what's in a name?

Jeffrey S Hoch1, Carolyn S Dewa.   

Abstract

OBJECTIVE: This paper describes the main types of economic evaluation techniques.
METHOD: To examine the strengths and limitations of different types of economic evaluations, we used a hypothetical example to review the reasoning underlying each method and to illustrate when it is appropriate to use each method.
RESULTS: The choice of economic evaluation method reflects a decision about what should represent "success" and how success should be valued. Measures of benefit and cost must be considered systematically and simultaneously. Claiming that a new treatment is cost-effective requires making a value judgment based on the personal beliefs of the claimant. Even when cost and effect data are objective, a verdict of cost-effective is subjective. The conclusions of an economic study can change significantly, depending on which patient outcome is used to measure success.
CONCLUSIONS: Clinicians must be sure that important patient outcomes are not excluded from economic evaluations. Economic evaluation is a process designed to produce an estimate rather than a decision. New treatment can be more costly and still be cost-effective (if the extra benefit is valued more than the extra cost to produce it). However, since economic evaluation does not explicitly consider a decision maker's available budget, a new treatment can be deemed cost-effective but too expensive to approve.

Entities:  

Mesh:

Year:  2005        PMID: 15830826     DOI: 10.1177/070674370505000305

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  6 in total

1.  Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

2.  Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation.

Authors:  Hui Shao; Shuang Yang; Vivian Fonseca; Charles Stoecker; Lizheng Shi
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

3.  Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma.

Authors:  M Dieng; A E Cust; N A Kasparian; P Butow; D S J Costa; S W Menzies; G J Mann; R L Morton
Journal:  BMJ Open       Date:  2016-10-06       Impact factor: 2.692

Review 4.  A systematic review of economic evaluations for donor human milk versus standard feeding in infants.

Authors:  Mandana Zanganeh; Mary Jordan; Hema Mistry
Journal:  Matern Child Nutr       Date:  2021-02-02       Impact factor: 3.092

5.  A systematic review of economic evaluations of cervical cancer screening methods.

Authors:  Thatohatsi Sefuthi; Lungiswa Nkonki
Journal:  Syst Rev       Date:  2022-08-09

6.  A framework for the next generation of risk science.

Authors:  Daniel Krewski; Margit Westphal; Melvin E Andersen; Gregory M Paoli; Weihsueh A Chiu; Mustafa Al-Zoughool; Maxine C Croteau; Lyle D Burgoon; Ila Cote
Journal:  Environ Health Perspect       Date:  2014-04-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.